Isopropyl Alcohol

Isopropyl Alcohol

SCHEMBL5722155

Br.CC(C)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Isopropyl Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117720591-A Synthesis method of 14-methyl ether epirubicin 浙江亚瑟医药有限公司 2024-03-19 CN claimed
CN-108658851-A Chloro- 3- methyl -6- acyl amino pyridines of 2- and its preparation method and application 山东特珐曼药业有限公司 2018-10-16 CN claimed
CN-117720591-A Synthesis method of 14-methyl ether epirubicin 浙江亚瑟医药有限公司 2024-03-19 CN disclosed
CN-114685399-A Preparation method of urapidil intermediate 1- (2-methoxyphenyl) piperazine and salt thereof 河北广祥制药有限公司 2022-07-01 CN disclosed
CN-106316985-B Beta type efficient vortioxetine hydrobromide crystal transformation method 郑州深蓝海生物医药科技有限公司 2021-11-09 CN disclosed
CN-106316985-B Beta type efficient vortioxetine hydrobromide crystal transformation method 郑州深蓝海生物医药科技有限公司 2021-11-09 CN disclosed
CN-108440570-B Preparation method of ceftiofur ester compound or halogen salt thereof 济宁市化工研究院 2020-12-04 CN disclosed
CN-111601806-A ROR gamma inhibitors 生命医药有限责任公司 2020-08-28 CN disclosed
US-20180243309-A1 TOPICAL ANTIVIRAL COMPOSITIONS TOPICAL REMEDY LLC (US) 2018-08-30 US disclosed
EP-3344265-A1 TOPICAL ANTIVIRAL COMPOSITIONS Topical Remedy, LLC (US) 2018-07-11 EP disclosed
US-9822086-B2 Process for the preparation of vortioxetine salts EGIS GYOGYSZERGYAR ZRT. (HU) 2017-11-21 US disclosed
CN-104736526-A Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usage HANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO LTD 2015-06-24 CN disclosed
WO-2015035802-A1 VORTIOXETINE SALT AND CRYSTAL THEREOF, THEIR PREPARATION METHOD, PHARMACEUTICAL COMPOSITIONS AND USAGE 杭州普晒医药科技有限公司 (CN) 2015-03-19 WO disclosed
EP-1686967-A2 CARVEDILOL FREE BASE, SALTS, ANHYDROUS FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULATIONS, AND TREATMENT OR DELIVERY METHODS SB Pharmco Puerto Rico Inc (PR) 2006-08-09 EP disclosed
WO-2005051325-A2 CARVEDILOL COMPOSITIONS METHODS OF TREATMENT AND DELIVERY SB PHARMCO PUERTO RICO INC. (PR) 2005-06-09 WO disclosed
US-6114565-A Process for obtaining nitriles MILLENNIUM SPECIALTY CHEMICALS (US) 2000-09-05 US disclosed
WO-1998024789-A1 PROCESS FOR MAKING η-METHYLENE-10-DEAZAAMINOPTERIN (MDAM) BIONUMERIK PHARMACEUTICALS, INC. (US) 1998-06-11 WO disclosed
US-4594342-A Anticoagulants TANABE SEIYAKU CO., LTD. (JP) 1986-06-10 US disclosed
US-4488914-A INDIUM PHOSPHIDE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 1984-12-18 US disclosed
US-3960959-A N,N'-bis{6-[(3,4-dihydroxyphenyl)alkylamino]-hexyl}hexamethylenediamines and the salts thereof SANDOZ LTD. (CH) 1976-06-01 US disclosed